Literature DB >> 2467878

Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunization.

P J Van der Heijden1, A T Bianchi, B A Bokhout, M Dol, J W Scholten, W Stok.   

Abstract

The intestinal immune response of mice against ovalbumin (OVA) was quantified by isolating lymphoid cells from the small intestine (SI) and testing them for antigen-specific immunoglobulin (Ig) secretion. The isolation procedure for functionally active lymphoid cells from the SI, originally developed to quantify the number of 'background' Ig-secreting cells in the SI, proved to be a useful method for evaluating antigen-specific intestinal immune responses quantitatively. The method was able to detect antigen-specific antibody-secreting cells (ASC) in the SI even when these cells occurred at a minimum frequency of only 0.006%. When mice were primed intraperitoneally (i.p.) with polymerized OVA and given an oral OVA booster immunization, OVA-specific ASC appeared in the SI from Day 3 after booster. After i.p. priming and an i.p. booster these cells could not be detected in the SI. The OVA-specific IgA-ASC responses in various organs after oral booster immunization were compared. From Day 5 after booster, when the response peaked, most OVA-specific IgA-ASC occurred in the SI. This suggested that these cells are mainly responsible for the OVA-specific antibodies demonstrated by ELISA in intestinal secretions from Day 6 after oral booster immunization. It is concluded that the quantitative method used in this study detects antigen-specific ASC in the SI with great sensitivity and could be used to evaluate immunization regimes aimed at inducing intestinal mucosal immune responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467878      PMCID: PMC1385228     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

Review 1.  Transport models for secretory IgA and secretory IgM.

Authors:  P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

2.  Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

3.  Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine.

Authors:  M D Davies; D M Parrott
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

4.  A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions.

Authors:  C O Elson; W Ealding; J Lefkowitz
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

5.  Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.

Authors:  F T Koster; N F Pierce
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

6.  Comparative aspects of the transport of immunoglobulin A from blood to bile.

Authors:  J G Hall; L A Gyure; A W Payne
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

7.  Special features of the priming process for a secretory IgA response. B cell priming with cholera toxin.

Authors:  J A Fuhrman; J J Cebra
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

8.  Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. II. Terminal differentiation of postswitch sIgA-bearing Peyer's patch B cells.

Authors:  H Kawanishi; L Saltzman; W Strober
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

9.  Systemic tolerance and secretory immunity after oral immunization.

Authors:  S J Challacombe; T B Tomasi
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro.

Authors:  H Kawanishi; L E Saltzman; W Strober
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  1 in total

1.  Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces.

Authors:  Nicole A Judge; Hugh S Mason; Alison D O'Brien
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.